methyllycaconitine has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Dong, H; Du, K; Han, H; Hou, L; Hu, S; Huang, Y; Li, S; Lu, Y; Mu, J; Pei, Y; Wang, W; Xiong, L; Zhang, Z; Zhao, Y | 1 |
1 other study(ies) available for methyllycaconitine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Activation of cholinergic anti-inflammatory pathway contributes to the protective effects of 100% oxygen inhalation on zymosan-induced generalized inflammation in mice.
Topics: Aconitine; Animals; Cytokines; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Lung; Male; Mecamylamine; Mice; Mice, Inbred ICR; Myocardium; Nicotinic Antagonists; Oxygen; Receptors, Nicotinic; Respiratory Insufficiency; Systemic Inflammatory Response Syndrome; Vagotomy; Zymosan | 2012 |